Finance

Lists
603193:SHA
Runben Biotechnology Co Ltd
CNÂ¥20.25
+1.25%
(+0.25) 1D
Sep 30, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603193...
Open
CNÂ¥20.01
High
CNÂ¥20.49
Low
CNÂ¥20.01
Mkt. cap
8.19B
Avg. vol.
3.07M
Volume
1.83M
Dividend
2.67%
Quarterly dividend
CNÂ¥0.14
Ex-dividend date
Sep 21, 2026
P/E ratio
23.27
52-wk high
CNÂ¥28.59
52-wk low
CNÂ¥17.77
EPS
CNÂ¥0.87
No. of employees
1K
Open
CNÂ¥20.01
High
CNÂ¥20.49
Low
CNÂ¥20.01
Mkt. cap
8.19B
Avg. vol.
3.07M
Volume
1.83M
Dividend
2.67%
Quarterly dividend
CNÂ¥0.14
Ex-dividend date
Sep 21, 2026
P/E ratio
23.27
52-wk high
CNÂ¥28.59
52-wk low
CNÂ¥17.77
EPS
CNÂ¥0.87
No. of employees
1K
News stories
From web sources and news partners
About Runben Biotechnology Co Ltd
CEO-
Employees1.02K
Founded1993
Headquarters-
SectorPersonal care products
Websiterunben.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
342.41M
307.27M
267.09M
786.78M
Cost of goods sold
138.21M
130.24M
109.25M
310.05M
Cost of revenue
138.21M
130.24M
109.25M
310.05M
Research and development expenses
8.74M
12.46M
8.38M
8.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
107.83M
126.19M
95.26M
263.67M
Operating expense
116.04M
142.36M
106.00M
282.96M
Total operating expenses
254.26M
272.60M
215.25M
593.00M
Operating income
88.16M
34.67M
51.84M
193.77M
Other non operating income
-82.64K
96.83K
-78.74K
-245.68K
EBT including unusual items
93.42M
48.69M
57.21M
202.39M
EBT excluding unusual items
95.58M
43.53M
56.27M
196.37M
Income tax expense
14.89M
234.06K
4.57M
29.94M
Effective tax rate
15.94%
0.48%
7.99%
14.79%
Other operating expenses
1.92M
4.47M
2.11M
7.18M
Net income
78.52M
48.45M
52.64M
172.46M
Net profit margin
22.93%
15.77%
19.71%
21.92%
Earnings per share
-
-
-
-
Interest and investment income
7.50M
8.73M
4.52M
2.91M
Interest expense
-18.73K
-15.50K
-12.23K
-8.94K
Net interest expenses
7.48M
8.71M
4.51M
2.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
93.06M
39.81M
56.98M
199.34M
Gain or loss from assets sale
80.15K
-80.39K
-
2.02K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps